PANoptosis links gut dysbiosis to obstructive sleep apnea-associated atherosclerosis: a gut-vascular inflammatory axis
Frontiers in Immunology · 09.07.2026 · 17
DOI: 10.3389/fimmu.2026.1901792 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 09.07.2026. Verfasst von Ji An Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine School of Basic Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Atherosclerosis, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province, Chengdu University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Obstructive sleep apnea (OSA) is increasingly recognized as an independent contributor to atherosclerotic cardiovascular disease, yet the mechanisms linking nocturnal intermittent hypoxia (IH) to plaque progression remain incompletely understood. Beyond oxidative stress and sympathetic activation, emerging evidence suggests that the gut may function as a critical relay organ between OSA and vascular injury. IH reshapes the intestinal ecosystem by altering microbial composition, weakening epithelial and mucus barrier integrity, and remodeling microbial metabolites, thereby increasing systemic exposure to microbial ligands and potentially pro-atherogenic metabolic signals, while reducing protective short-chain fatty acids. Trimethylamine N-oxide(TMAO) and imidazole propionate (ImP) are discussed as representative microbiota-derived metabolites implicated in atherosclerosis, although direct evidence linking OSA-related IH to increased circulating TMAO in human cohorts remains limited. These intestinal inflammatory and metabolic inputs may amplify endothelial dysfunction, macrophage activation, and chronic vascular inflammation. We propose that PANoptosis, an integrated inflammatory cell death program involving pyroptosis, apoptosis, and necroptosis, may represent a plausible downstream inflammatory cell death mechanism through which dysbiosis-associated and plaque-local stressors converge to promote plaque injury. This review summarizes convergent indirect evidence supporting a gut dysbiosis-PANoptosis-vascular injury hypothesis, and discusses potential therapeutic implications for OSA-associated atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine School of Basic Medicine, Chengdu, China.
- Traditional Chinese Medicine Hospital of Meishan, Affiliated Meishan Hospital of Chengdu University of TCM, Meishan, China.
Förderung
- Science and Technology Department of Sichuan Province
- Chengdu University of Traditional Chinese Medicine
Zitieren
APA
Li, J. A., Dai, Y., Zhang, H., & Zhou, X. (2026). PANoptosis links gut dysbiosis to obstructive sleep apnea-associated atherosclerosis: a gut-vascular inflammatory axis. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1901792
Vancouver
Li JA, Dai Y, Zhang H, Zhou X. PANoptosis links gut dysbiosis to obstructive sleep apnea-associated atherosclerosis: a gut-vascular inflammatory axis. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1901792
BibTeX
@article{Li2026,
author = {Li, Ji An and Dai, Yunyan and Zhang, Hong and Zhou, Xin},
title = {PANoptosis links gut dysbiosis to obstructive sleep apnea-associated atherosclerosis: a gut-vascular inflammatory axis},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1901792}
}
EUVIMED